Pricing

Invest in discovery.
Not infrastructure.

From academic research to pharma-grade drug repurposing pipelines. GaiaLab scales with your ambition.

By the numbers

—
Unique drug-disease pairs benchmarked
—
Retrospective ClinicalTrials.gov concordance (not efficacy)
76+
Live databases integrated
8
analysis pipeline stages

Frequently asked questions

What is GaiaLab?
GaiaLab transforms gene lists into drug repurposing candidates, resistance mutation cascades, pathway insights, and clinical trial hypotheses — grounded in integrated biological sources with explicit citation and evidence checks. It runs as a web app, API, and MCP server for Claude.
Do I need bioinformatics expertise?
No. Enter your gene list and disease context — GaiaLab handles the rest. Results are explained in plain language for researchers, clinicians, and executives.
How is hit rate calculated?
We check every drug-disease prediction against ClinicalTrials.gov. "Confirmed" means the drug has registered trial evidence for that disease. See our full validation report.
Is there a free tier?
Yes — the web app at gailabai.com is free to use. The Research plan adds volume, priority processing, and API access.
Can we use GaiaLab for pharma drug discovery?
GaiaLab can support bounded validation-pilot and enterprise discussions for non-confidential research workflows. Security, data-handling, hosting, export, support, and SLA terms must be agreed for the specific engagement; GaiaLab does not currently claim SOC 2 certification. Contact contact@gailabai.com.